McKesson Corporation Announces Results Of Celesio AG Takeover Offer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that the results of the initial acceptance period of the voluntary public takeover offer (“Takeover Offer”) for the remaining shares of Celesio AG (“Celesio”) have been published. McKesson now owns 75.7% of Celesio shares on a fully diluted basis.

Help employers find you! Check out all the jobs and post your resume.

Back to news